ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Telehealth education for patients with cancer: a standalone solution for symptom relief?
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Telehealth education alone is not enough: toward closed-loop supportive oncology.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
Abstract
backgroundTelehealth-delivered education offers a practical approach to chemotherapy teaching and symptom self-management support. Advanced practice providers (APPs) play an increasingly vital role in guiding oncology patients through treatment, particularly in managing symptoms and reducing preventable emergency department (ED) use. This study evaluated whether an APP-led telehealth symptom education and monitoring (TSEM) intervention improved symptom self-management engagement and reduced ED utilization in patients with cancer.
methodsThis retrospective study included 120 patients with gastrointestinal (GI), lung, or sarcoma cancers treated at a single academic institution. The intervention group (n = 61) received a tailored telehealth education session from specialized oncology APPs within seven days of treatment initiation. The control group (n = 59) received standard patient education. Outcomes included ED visits and symptom self-management engagement, measured via medical record-documented patient-initiated symptom support calls. Data were analyzed using multivariable binary logistic, linear, and negative-binomial regression models adjusted for demographic, clinical covariates.
resultsThe intervention did not significantly reduce ED utilization overall. Patients with GI cancer in the TSEM group had increased odds of ED visits. However, patients in the TSEM group made significantly more symptom self-management calls (74% higher rate; p < 0.05), especially those with GI cancer, suggesting increased patient engagement in managing treatment-related symptoms.
conclusionsAPP-led telehealth education enhanced patient engagement in symptom self-management but did not reduce ED visits. Tailored, cancer-specific education delivered by APPs may empower patients to manage symptoms earlier. Further prospective, multi-site research is needed to assess the long-term impact on acute care utilization and quality outcomes in broader, diverse oncology populations.
Indexed as
Identifiers
41781779What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.